These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3443354)

  • 1. [Diagnostic value of the Gynaegnost test in the diagnosis of carcinoma in situ and invasive cancer of the uterus].
    Madej J; Lukomski L
    Ginekol Pol; 1987 Sep; 58(9):577-81. PubMed ID: 3443354
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic value of increased lactate dehydrogenase activity in vaginal secretions for the early detection of diseases requiring treatment of the female genitals and breast].
    Horbach L; Hilgarth M; Melchert F; Stegner HE
    Geburtshilfe Frauenheilkd; 1984 Oct; 44(10):627-35. PubMed ID: 6569843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Validity of Gynaegnost in the follow-up of patients treated for ovarian cancer].
    Cerejeira L; Pinto-Ferreira MM; Otilia-Bacelar MO; Moutinho J
    Rev Fr Gynecol Obstet; 1989 Apr; 84(4):347-9. PubMed ID: 2734533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of carcinoma of the cervix on the L-lactate-nicotinamide-adenine dinucleotide oxidoreductase activity in vaginal aspirates.
    Emes AV; Latner AL; Guthrie D; Philips PR; Way SA
    Br J Obstet Gynaecol; 1981 Jan; 88(1):36-41. PubMed ID: 7459289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal fluid enzyme patterns in benign and malignant lesions of the female genital tract.
    Muir GG; Valteris G
    J Clin Pathol; 1969 Sep; 22(5):593-7. PubMed ID: 5364445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactic dehydrogenase isozymes in vaginal pools of patients with pelvic malignant tumors.
    Dorrance W; Findle E
    Surg Gynecol Obstet; 1969 Sep; 129(3):547-50. PubMed ID: 5820937
    [No Abstract]   [Full Text] [Related]  

  • 7. [Early detection of gynecologic neoplasms: value of lactate dehydrogenase in vaginal secretions as a tumor marker].
    Berger C; Lépine M; Meandzija M; Szalmay G; Köppel R
    Gynakol Rundsch; 1985; 25(1):31-9. PubMed ID: 3979919
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison of the indices of occurrence of the diagnoses as a method of assessing the quality of histological diagnostics (using intraepithelial and invasive uterine tumors as an example)].
    Rybakova MG; Koval'skiĭ GB; Chibisov VN; Nikonova OA; Nikonov AA
    Arkh Patol; 2003; 65(5):40-3. PubMed ID: 14664148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis of malignant tumors of the uterus by transabdominal ultrasonography: a utopia?].
    Hänggi W; Dürig P; Herrmann U
    Ultraschall Med; 1990 Aug; 11(4):169-71. PubMed ID: 2259907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accidental finding of carcinoma in the uterus removed because of benign disease.
    Klauber E
    Neoplasma; 1974; 21(4):471-7. PubMed ID: 4431544
    [No Abstract]   [Full Text] [Related]  

  • 11. [The clinical application of the qualitative cervical cystosmear (author's transl)].
    Rummel HH; Bothmann G; Bräunig G
    Geburtshilfe Frauenheilkd; 1974 Aug; 34(8):607-10. PubMed ID: 4426499
    [No Abstract]   [Full Text] [Related]  

  • 12. [Contribution to the enzymology of vaginal secretion in some diseases of the vagina and the uterine cervix].
    Kohoutek M; Jícha J; Jirkalová V; Andrýs J
    Cesk Gynekol; 1967 Feb; 32(1):7-10. PubMed ID: 6044959
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experience and results with a lactate dehydrogenase marker in vaginal secretions of women at high risk for endometrial cancer].
    Osorio MT; Morais R; Santos E; Silva D; Abraul E; Silva MM; Azinhais A; Oliveira F
    Rev Fr Gynecol Obstet; 1989 Jan; 84(1):1-4. PubMed ID: 2648543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial hyperplasia and carcinoma. Diagnostic considerations.
    Norris HJ; Tavassoli FA; Kurman RJ
    Am J Surg Pathol; 1983 Dec; 7(8):839-47. PubMed ID: 6660354
    [No Abstract]   [Full Text] [Related]  

  • 15. Minimal uterine serous carcinoma: current concepts in diagnosis and prognosis.
    Rabban JT; Zaloudek CJ
    Pathology; 2007 Feb; 39(1):125-33. PubMed ID: 17365828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The early diagnosis of carcinoma of the female genital tract. II. Vaginal fluid 6-phosphogluconate dehydrogenase activity as a test for carcinoma of the cervix.
    Moukter M; Higgins G
    J Obstet Gynaecol Br Commonw; 1965 Oct; 72(5):684-90. PubMed ID: 5891592
    [No Abstract]   [Full Text] [Related]  

  • 17. Carcinoma in situ of the endometrium.
    Sommers SC
    Am J Clin Pathol; 1979 Jul; 72(1):130-1. PubMed ID: 453103
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tumor-classification following the TNM-system. 3. Corpus-, vagina-, and vulvar carcinoma].
    Susemihl D
    Fortschr Med; 1976 Nov; 94(31):1761-4. PubMed ID: 1002080
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intrauterine ultrasonic tomography (IUT): comparison with macroscopic sections].
    Hötzinger H; Becker H; Becker V
    Geburtshilfe Frauenheilkd; 1984 Apr; 44(4):219-24. PubMed ID: 6562987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum enzyme activity in malignant conditions of the uterus (uterine cancer) and the effect of uterine trauma as well as of radiotherapy on the enzyme activity. I.
    Widholm O; Tarjanne H
    Ann Chir Gynaecol Fenn Suppl; 1967; 161():7-11. PubMed ID: 5243868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.